BMI, Survival Linked in NSCLC Treated With Atezolizumab
Overall, progression - free survival improved for patients with high BMI; link strongest with high PD - L1 expression
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pharmacy, Pulmonology, Journal, Source Type: news
More News: Cancer & Oncology | Non-Small Cell Lung Cancer